High-dose voriconazole in a critically ill pediatric patient with neuroblastoma

Pediatric Infectious Disease Journal

Volumn 27, Issue 2, 2008, Pages 189-190

  Alffenaar, Jan Willem C ^a   Doedens, Rienus A ^a   Groninger, Ellis ^a   Kosterink, Jos G W ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE; ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

AREA UNDER THE CURVE; CANDIDA PARAPSILOSIS; CASE REPORT; CHILD; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LETTER; MALE; MYCOSIS; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; BLOOD; CANDIDIASIS; CRITICAL ILLNESS; LUNG DISEASE;

ANTIFUNGAL AGENTS; CANDIDIASIS; CHILD, PRESCHOOL; CRITICAL ILLNESS; HUMANS; LUNG DISEASES; MALE; NEUROBLASTOMA; PYRIMIDINES; TRIAZOLES;

EID: 40949165429     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31815c89fd     Document Type: Letter

References (16)

1. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347:240-247.
2. Joseph TA, Pyati SP, Jacobs N. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med. 1998;152:35-40.
3. Robbins JB, McCracken GH Jr, Gotschlich EC, Orskov F, Orskov I, Hanson LA. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med. 1974;290:1216-1220.
4. Sarff LD, McCracken GH, Schiffer MS, et al. Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet. 1975;1:1099-1104.
5. Grauel EL, Halle E, Bollmann R, Buchholz P, Buttenberg S. Neonatal septicaemia-incidence, etiology and outcome. A 6-year analysis. Acta Paediatr Scand. 1989;360:113-119.
6. Headings DL, Overall JC Jr. Outbreak of meningitis in a newborn intensive care unit caused by a single Escherichia coli K1 serotype. J Pediatr. 1977;90:99-102.
7. Comite de l'antibiogramme de la Societe Francaise de Microbiologie. Communique. 2006. Available at: [http://www.sfm.asso.fr].
8. Bingen-Bidois M, Clermont O, Bonacorsi S, et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing patho- genicity-island like domain. Infect Immun. 2002;70:3216-3226.
9. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
10. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000; 66:4555-4338.
11. Bonacorsi S, Clermont O, Tinsley C, et al. Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis- associated strains. Infect Immun. 2000;68:2096 -2101.
12. Bradley JS. Neonatal infections. Pediatr Infect Dis. 1985;4:315-320.
13. Galask RP, Larsen B, Ohm MJ. Vaginal flora and its role in disease entities. Clin Obstet Gynecol. 1976;19:61-81.
14. Alarcon A, Pana P, Salas S, Sancha M, Omenanca F. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J. 2004;23:295-299.
15. Mercer BM, Carr TL, Beazley DD, et al. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol. 1999;181:816-821.
16. Berg RD. Translocation of indigenous bacteria from the intestinal tract. In Hentges DJ, ed. Human Intestinal Microflora in Health and Disease. New York, NY: Academic Press; 1983:333-351.